{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:11:17Z","timestamp":1778749877461,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CE20232023"],"award-info":[{"award-number":["CE20232023"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CZ20210006"],"award-info":[{"award-number":["CZ20210006"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CE20222022"],"award-info":[{"award-number":["CE20222022"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CJ20220179"],"award-info":[{"award-number":["CJ20220179"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CJ20235010"],"award-info":[{"award-number":["CJ20235010"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CQ20230011"],"award-info":[{"award-number":["CQ20230011"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CQ20220029"],"award-info":[{"award-number":["CQ20220029"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.prp.2025.156176","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:44:19Z","timestamp":1755067459000},"page":"156176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of the LAMP-IDE-AI platform for the detection of the HLA-B*15:02 allele in clinical application"],"prefix":"10.1016","volume":"274","author":[{"given":"Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongzhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2784-7058","authenticated-orcid":false,"given":"Qiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156176_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1039\/C9AY02246E","article-title":"Loop-mediated isothermal amplification (LAMP) \u2013 review and classification of methods for sequence-specific detection","volume":"12","author":"Becherer","year":"2020","journal-title":"Anal. Methods"},{"key":"10.1016\/j.prp.2025.156176_bib2","first-page":"1017","article-title":"Treatment with anti-epileptic drugs","volume":"34","author":"Berkovic","year":"2005","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.prp.2025.156176_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.seizure.2020.10.018","article-title":"Current role of carbamazepine and oxcarbazepine in the management of epilepsy","volume":"83","author":"Beydoun","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.prp.2025.156176_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225028","article-title":"Carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap in a Filipino with positive hla-b75 serotype","volume":"2018","author":"Capule","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.prp.2025.156176_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-Year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.prp.2025.156176_bib6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/WNL.0000000000001034","article-title":"Effects of a hla-b*15:02 screening policy on antiepileptic drug use and severe skin reactions","volume":"83","author":"Chen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156176_bib7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.0000000000002484","article-title":"Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment","volume":"86","author":"Chen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156176_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1373\/clinchem.2009.127894","article-title":"New testing approach in HLA genotyping helps overcome barriers in effective clinical practice","volume":"55","author":"Cheng","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.prp.2025.156176_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"hla-b alleles associated with severe cutaneous reactions to antiepileptic drugs in han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.prp.2025.156176_bib10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/epi.16053","article-title":"Cost-effectiveness of screening for hla-b*1502 prior to initiation of carbamazepine in epilepsy patients of asian ancestry in the United States","volume":"60","author":"Choi","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.prp.2025.156176_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156176_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.prp.2025.156176_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1040638720905833","article-title":"Guidelines for sanger sequencing and molecular assay monitoring","volume":"32","author":"Crossley","year":"2020","journal-title":"J. Vet. Diagn. Invest"},{"key":"10.1016\/j.prp.2025.156176_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.seizure.2018.06.024","article-title":"Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in asian populations: a meta-analysis","volume":"60","author":"Deng","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.prp.2025.156176_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(21)00023-5","article-title":"Epilepsy in China: major progress in the past two decades","volume":"20","author":"Ding","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.prp.2025.156176_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jmoldx.2018.01.005","article-title":"Rapid, Loop-Mediated isothermal amplification detection of celiac disease risk alleles","volume":"20","author":"Erlichster","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2025.156176_bib17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, hla-b*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.prp.2025.156176_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e328328f276","article-title":"Genetic basis for idiosyncratic reactions to antiepileptic drugs","volume":"22","author":"Franciotta","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.prp.2025.156176_bib19","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.prp.2025.156176_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2016.12.024","article-title":"Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"76","author":"Hsu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.prp.2025.156176_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.prp.2025.156176_bib22","doi-asserted-by":"crossref","first-page":"45553","DOI":"10.1038\/srep45553","article-title":"hla-b*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis","volume":"7","author":"Jaruthamsophon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156176_bib23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"hla-b*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.prp.2025.156176_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22242","article-title":"External quality assessment for laboratory testing of hla-b*15:02 allele in relation to carbamazepine therapy","volume":"32","author":"Lin","year":"2018","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.prp.2025.156176_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/pgs-2017-0189","article-title":"Association between hla-b*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis","volume":"19","author":"Liu","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.prp.2025.156176_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between hla-b*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.prp.2025.156176_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humimm.2015.07.193","article-title":"Clinical validation of next generation sequencing for HLA typing using trusight HLA","volume":"76","author":"Montgomery","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.prp.2025.156176_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40272-023-00570-1","article-title":"Pediatric status epilepticus: treat early and avoid delays","volume":"25","author":"Morgan","year":"2023","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.prp.2025.156176_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions","volume":"93","author":"Mullan","year":"2019","journal-title":"HLA"},{"key":"10.1016\/j.prp.2025.156176_bib30","doi-asserted-by":"crossref","first-page":"5376476","DOI":"10.1155\/2018\/5376476","article-title":"Anticancer drugs induced severe adverse cutaneous drug reactions: an updated review on the risks associated with anticancer targeted therapy or immunotherapies","volume":"2018","author":"Ng","year":"2018","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.prp.2025.156176_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-mediated isothermal amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2025.156176_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.prp.2025.156176_bib33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical pharmacogenetics implementation consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.prp.2025.156176_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.prp.2025.156176_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphar.2020.00078","article-title":"Genetic diversity of HLA class I and class II alleles in Thai populations: contribution to Genotype-Guided therapeutics","volume":"11","author":"Satapornpong","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.prp.2025.156176_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yebeh.2011.03.037","article-title":"Antiepileptic drug discovery: does mechanism of action matter?","volume":"21","author":"Schmidt","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.prp.2025.156176_bib37","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.07.020706","article-title":"Prevalence of epilepsy in China between 1990 and 2015: a systematic review and meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.prp.2025.156176_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bios.2018.01.063","article-title":"An interdigitated electrode biosensor platform for rapid hla-b*15:02 genotyping for prevention of drug hypersensitivity","volume":"111","author":"Soraya","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.prp.2025.156176_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081931","article-title":"Loop-Mediated isothermal amplification (LAMP): the better sibling of PCR?","volume":"10","author":"Soroka","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156176_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11596-014-1247-7","article-title":"Association of hla-b*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China","volume":"34","author":"Sun","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol. Med Sci."},{"key":"10.1016\/j.prp.2025.156176_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb1514s105","article-title":"Loop-mediated isothermal amplification for detection of nucleic acids","volume":"105","author":"Tanner","year":"2014","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.prp.2025.156176_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.prp.2025.156176_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdin.2022.12.002","article-title":"Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the shizuoka kokuho database","volume":"11","author":"Ubukata","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.prp.2025.156176_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jmoldx.2016.03.009","article-title":"Performance characteristics and validation of Next-Generation sequencing for human leucocyte antigen typing","volume":"18","author":"Weimer","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2025.156176_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ijd.15792","article-title":"hla-b*15:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in hla-b*15:02 negative Chinese","volume":"61","author":"Wong","year":"2022","journal-title":"Int J. Dermatol."},{"key":"10.1016\/j.prp.2025.156176_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1744-313X.2010.00910.x","article-title":"hla-b*15 subtypes distribution in han population in Beijing, China, as compared with those of other populations","volume":"37","author":"Yang","year":"2010","journal-title":"Int J. Immunogenet."},{"key":"10.1016\/j.prp.2025.156176_bib47","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1038\/srep26533","article-title":"Establishment and application of a real-time loop-mediated isothermal amplification system for the detection of CYP2C19 polymorphisms","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:27:35Z","timestamp":1778747255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"alternative-id":["S0344033825003693"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156176","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the LAMP-IDE-AI platform for the detection of the HLA-B*15:02 allele in clinical application","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156176"}}